Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$1.07B |
| 2 |
Nike
NKE
|
+$1B |
| 3 |
NXP Semiconductors
NXPI
|
+$922M |
| 4 |
Qualcomm
QCOM
|
+$843M |
| 5 |
Starbucks
SBUX
|
+$830M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$2.36B |
| 2 |
Eli Lilly
LLY
|
+$1.14B |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$967M |
| 4 |
Amazon
AMZN
|
+$883M |
| 5 |
Procter & Gamble
PG
|
+$856M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.98% |
| 2 | Technology | 16.65% |
| 3 | Financials | 14.54% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.97T
| $16.5B | 3.32% |
64,099,085
+3,034,209
| +5% | +$823M |
2013 Q2
36 quarters
|
|
2
UnitedHealth
UNH
$340B
| $13.6B | 2.75% |
26,538,607
-1,456,970
| -5% | -$732M |
2013 Q2
36 quarters
|
|
3
Pfizer
PFE
$161B
| $11.5B | 2.31% |
219,171,647
+2,497,346
| +1% | +$127M |
2013 Q2
36 quarters
|
|
4
Apple
AAPL
$4.91T
| $9.07B | 1.83% |
66,358,821
-774,725
| -1% | -$117M |
2013 Q2
36 quarters
|
|
5
Alphabet (Google) Class A
GOOGL
$4.3T
| $7.79B | 1.57% |
71,481,180
-6,480,960
| -8% | -$763M |
2015 Q4
26 quarters
|
|
|
6
Eli Lilly
LLY
$1.05T
| $7.6B | 1.53% |
23,437,256
-3,786,064
| -14% | -$1.14B |
2013 Q2
36 quarters
|
|
|
7
Amazon
AMZN
$2.83T
| $6.26B | 1.26% |
58,953,477
-7,052,503
| -11% | -$883M |
2013 Q2
36 quarters
|
|
|
8
Procter & Gamble
PG
$351B
| $5.95B | 1.2% |
41,397,225
-5,696,730
| -12% | -$856M |
2013 Q2
36 quarters
|
|
|
9
TJX Companies
TJX
$153B
| $5.73B | 1.15% |
102,541,948
+17,625,647
| +21% | +$1.07B |
2013 Q2
36 quarters
|
|
10
Johnson & Johnson
JNJ
$630B
| $5.24B | 1.06% |
29,531,262
-3,241,332
| -10% | -$578M |
2013 Q2
36 quarters
|
|
11
Texas Instruments
TXN
$259B
| $5.23B | 1.05% |
34,008,283
+2,595,398
| +8% | +$437M |
2013 Q2
36 quarters
|
|
12
JPMorgan Chase
JPM
$885B
| $4.99B | 1% |
44,287,167
+1,141,471
| +3% | +$141M |
2013 Q2
36 quarters
|
|
13
Mastercard
MA
$516B
| $4.92B | 0.99% |
15,584,686
-101,794
| -0.6% | -$35.1M |
2013 Q2
36 quarters
|
|
14
McDonald's
MCD
$166B
| $4.88B | 0.98% |
19,749,024
-1,012,896
| -5% | -$249M |
2013 Q2
36 quarters
|
|
15
Danaher
DHR
$155B
| $4.81B | 0.97% |
21,396,619
+1,006,000
| +5% | +$232M |
2013 Q2
36 quarters
|
|
|
SCHW
16
Charles Schwab
SCHW
$167B
| $4.78B | 0.96% |
75,689,429
-1,772,438
| -2% | -$122M |
2017 Q2
20 quarters
|
|
17
Elevance Health
ELV
$89.5B
| $4.75B | 0.96% |
9,847,831
-281,590
| -3% | -$139M |
2013 Q2
36 quarters
|
|
18
Chubb
CB
$132B
| $4.71B | 0.95% |
23,954,656
-3,172,905
| -12% | -$654M |
2013 Q2
36 quarters
|
|
19
Visa
V
$724B
| $4.6B | 0.93% |
23,365,127
+1,142,957
| +5% | +$236M |
2013 Q2
36 quarters
|
|
20
RTX Corp
RTX
$251B
| $4.49B | 0.9% |
46,701,977
-8,350,693
| -15% | -$803M |
2013 Q2
36 quarters
|
|
21
Humana
HUM
$51.9B
| $4.4B | 0.89% |
9,396,515
+621,139
| +7% | +$276M |
2013 Q2
36 quarters
|
|
22
Coca-Cola
KO
$379B
| $4.33B | 0.87% |
68,849,098
-11,804,940
| -15% | -$748M |
2013 Q2
36 quarters
|
|
23
Exelon
EXC
$43B
| $4.09B | 0.82% |
90,296,113
-2,913,844
| -3% | -$137M |
2013 Q2
36 quarters
|
|
24
Baxter International
BAX
$12.6B
| $3.98B | 0.8% |
61,887,205
+6,317,261
| +11% | +$458M |
2013 Q2
36 quarters
|
|
25
Northrop Grumman
NOC
$68.3B
| $3.82B | 0.77% |
7,974,522
-701,186
| -8% | -$322M |
2013 Q2
36 quarters
|
|
Similar funds
Wellington Management Group's Q2 2022 Portfolio in Review
As of Q2 2022, Wellington Management Group held 2,269 positions worth $497B, down 15% from $584B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wellington Management Group's Q2 2022 filing shows 173 new, 743 increased, 900 reduced and 213 closed positions. Its largest new stake was ESAB: 1,400,060 shares worth $61.3M. The largest sale was Bank of America, an estimated $2.36B.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Financials.
- Wellington Management Group's largest Q2 2022 buy was ESAB: 1,400,060 shares worth $61.3M.
- Wellington Management Group added most to TJX Companies in Q2 2022, an estimated $1.07B increase.
- Wellington Management Group's biggest Q2 2022 reduction was Bank of America, cutting an estimated $2.36B.
- Wellington Management Group fully exited Lamb Weston in Q2 2022, selling an estimated $206M.
- Wellington Management Group's ten largest holdings make up 18% of its $497B portfolio in Q2 2022.
- Wellington Management Group opened 173 new positions and closed 213 in Q2 2022.
- Wellington Management Group's portfolio value fell 15% quarter-over-quarter to $497B.
Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.